Prodynorphin allelic distribution in Scandinavian chronic alcoholics

Alcoholism: Clinical and Experimental Research

Volumn 21, Issue 7, 1997, Pages 1333-1336

  Geijer, T ^b   Jonsson E ^a   Neiman, J ^a   Gyllander, A ^a   Sedvall, G ^a   Rydberg, U ^a   Terenius, L ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Box 230   (Sweden)

Author keywords

Alcoholism; Genetics; Polymorphism; Prodynorphin

Indexed keywords

PRODYNORPHIN;

ADULT; AGED; ALCOHOLISM; ALLELE; ARTICLE; BASE PAIRING; CONTROLLED STUDY; EXON; FEMALE; GENETIC POLYMORPHISM; HUMAN; MAJOR CLINICAL STUDY; MALE; MARKER GENE; PRIORITY JOURNAL; SCANDINAVIA;

EID: 0343416376     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1997.tb04456.x     Document Type: Article

References (48)

1. Pickens RW, Svikis DS, McGue M, Lykken DT, Heston LL, Claytun PJ: Heterogeneity in the inheritance of alcoholism. Arch Gen Psychiatry 48:19-28, 1991
2. Cloninger CR, Bohman M, Sigvardsson S: Inheritance of alcohol abuse. Arch Gen Psychiatry 38:861-868, 1981
3. Cadoret RJ, Troughton E, O'Gorman TW, Heywood E: An adoption study of genetic and environmental factors in drug abuse. Arch Gen Psychiatry 43:1131-1136, 1986
4. Sigvardsson S, Bohman M, Cloninger CR: Replication of the Stockholm Adoption Study of alcoholism. Arch Gen Psychiatry 53:681-687, 1996
5. Kiianmaa K, Stenius K, Sinclair JD: Determinants of alcohol preference in the AA and ANA rat lines selected for differential ethanol intake. Alcohol Alcohol 1(Suppl): 115-420, 1991
6. Murphy JM, Gatto GJ, McBride WJ, et al: Operant responding for oral ethanol in the alcohol-preferring P and alcohol-nonpreferring NP lines of rat. Alcohol 6:127-131, 1989
7. Li T-K, Lumeng L: Alcohol preference and voluntary alcohol intakes of inbred rat strains and the NIH heterogeneous stock of rats. Alcohol Clin Exp Res 8:485-486, 1984
8. Fibiger HC, LePiane FG, Jacubovic A, Phillips AG: The role of dopamine in intracranial self-stimulation of the ventral tegmental area. J Neurosci 7:3888-3896, 1987
9. Corbett D, Wise RA: Intracranial self-stimulation in relation to the ascending dopaminergic systems of the midbrain: A movable electrode study. Brain Res 185:1-15, 1980
10. Fiorino DF, Coury A, Fibiger HC, Phillips AG: Electrical stimulation of reward sites in the ventral fegmental area increases dopamine transmission in the nucleus accumbens of rat. Behav Brain Res 55:131-141, 1993
11. Koob GF: Drugs of abuse: Anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177-184, 1992
12. Welzl H, Kuhn G, Huston JP: Self-administration of small amounts of morphine through glass micropipettes into ventral tegmental area of the rat. Neuropharmacology 28:1017-1023, 1989
13. Bozarth MA, Wise RA: Intracranial self-administration of morphine into the ventral tegmental area in rats. Life Sci 28:551-555, 1981
14. Hoebel BG, Monaco AP, Hernandez L, Aulisi EF, Stanley BG, Lenard L: Self-injection of amphetamine directly into the brain. Psychopharmacology 81:158-163, 1983
15. Mcbride WJ, Murphy JM, Gatto GJ, Levy AD, Yoshimoto K, Lumeng L, Li TK: CNS mechanisms of alcohol self-administration. Alcohol Alcohol 2(Suppl.):463-467, 1993
16. Di Chiara G, Imperato A: Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci 85:5274-5278, 1988
17. Grenhoff J, Aston-Jones G, Svensson TH: Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand 128:351-358, 1986
18. Brodie MS, Shefner SA, Dunwiddie TV: Ethanol increases the firing rale of dopamine neurons of the rat ventral tegmental area in vitro. Brain Res 508:65-69, 1990
19. Maisonneuve IM, Keller RW, Glick SD: Similar effects of D-amphetamine and cocaine on extracellular dopamine levels in medial prefrontal cortex of rats. Brain Res 535:221-226, 1990
20. Chen JP, Paredes W, Li J, Smith D, Lowinson J, Gardner EL: Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis. Psychopharmacology 102:156-162, 1990
21. Carboni E, Imperato A, Perezzani L, Di Chiara G: Amphetamine, cocaine, phencyclidine, and nomifensine increase extracellular dopamine concentrations preferentially in the nucleus accumbens of freely moving rats. Neuroscience 28:653-661, 1989
22. Gessa GL, Muntoni F, Collu M, Vargiu L, Mereu C: Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area. Brain Res 348:201-203, 1985
23. Krebs M-O, Gauchy C, Desban M, Glowinski J. Kemel M-L: Role of dynorphin and GABA in the inhibitory regulation of NMDA-induced dopamine release in striosome and matrix enriched areas of the rat striatum. J Neurosci 14:2435-2443, 1994
24. Smith JAM, Loughlin SE, Leslie FM: Kappa-opioid inhibition of >H-3
25. Ronken E, Mulder AH, Schoffelmeer NM: Interacting presynaptic kappa-opioid and GABA A receptors modulate dopamine release from rat striatal synaptosomes. J Neurochem 61:1634-1639, 1993
26. Manzanares J, Wagner EJ, Lookingland KJ, Moore KE: Effects of immunoneutralization of dynorphin 1-17 and dynorphin 1-8 on the activity of central dopaminergic neurons in the male rat. Brain Res 587:301-305, 1992
27. Herrera-Marschitz M, Christensson-Nylander I, Sharp T, Staines W, Reid M, Hökfelt T, Terenius L, Ungerstedt U: Striato-nigral dynorphin and substance P pathways in the rat. Exp Brain Res 64:193-207, 1986
28. Spanagel R, Herz A, Shippenberg TS: Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA 89:2046-2050, 1992
29. Devine DP, Leone P, Carlezon WA Jr, Wise RA: Ventral mesencephalic delta opioid receptors are involved in modulation of basal mesolimbic dopamine neurotransmission: An anatomical localization study. Brain Res 622:348-352, 1993
30. Kalivas P, Widerlov E, Stanley D, Bruse G, Prange A: Enkephalin action on the mesolimbic system: Adopamine dependent and dopamine-independent increase in locomotor activity. J Pharmacol Exp Ther 227:229-237, 1983
31. Jiang H, McGinty J, Hong J: Differential modulation of dynorphin and enkephalin by dopamine receptor subtypes. Brain Res 507:57-64, 1990
32. Li S, Jiang H, Stachowiak M, Hudson P, Owyang V, Nanry K, Tilson H, Hong J: Influence of nigrostriatal dopaminergic tone on the biosynthesis of dynorphin and enkephalin in rat striatum. Mol Brain Res 8:219-225, 1990
33. Engber TM, Boldry RC, Kuo S, Chase TN: Dopaminergic modulation of striatal neuropeptides: Differential effects of D1 and D2 receptor stimulation on somatostatin neuropeptide Y, neurotensin, dynorphin and enkephalin. Brain Res 581:261-268, 1992
34. Xu M, Moratella R, Gold LH, Hiroi N, Koob GF, Graybiel AM, Tonegawa S: Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and dopamine-mediated behavioral responses. Cell 79:729-742, 1994
35. Nylander I, Hyytiä P, Forsander O, Terenius L: Differences between alcohol-preferring (AA) and alcohol-avoiding (ANA) rats in the prodynorphin and proenkephalin systems. Alcohol Clin Exp Res 18:1272-1279, 1994
36. Seizinger BR, Bovermann K, Maysinger D, Höllt V, Herz A: Differential effects of acute and chronic ethanol treatment on particular opioid peptide systems in discrete regions of rat brain and pituitary. Pharmacol Biochem Behav 18:361-369, 1983
37. Przewlocka B, Laso'n W, Przewlocki R: Repeated ethanol administration decreases prodynorphin biosynthesis in the rat hippocampus. Neurosci Lett 134:195-198, 1992
38. Blum K, Briggs AH, Elston SFA, DeLallo L, Sheridon PJ: Reduced leucine-enkephalin-like immunoreactive substance in hamster basal ganglia after long term ethanol exposure. Science 216:1425-1427, 1982
39. Volpicelli JR, Clay KL, Watson NT, O'Brien CP: Naltrexone in the treatment of alcoholism: Predicting response to naltrexone. J Clin Psychiatry 56(Suppl. 7):39-44, 1995
40. Geijer T, Jönsson E, Neiman J, Persson M-L, Brené S, Gyllander A, Sedvall G, Rydberg U, Wasserman D, Terenius L: Tyrosine hydroxytase and dopamine D4 receptor allelic distribution in Scandinavian chronic alcoholics. Alcohol Clin Exp Res 21:35-39, 1997
41. Geijer T, Neiman J, Rydberg U, Gyllander A, Jönsson E, Sedvall G, Valverius P, Terenius L: Dopamine D2-receptor gene polymorphisms in Scandinavian chronic alcoholics. Eur Arch Psychiatry Clin Neurosci 244:26-32, 1994
42. Sedvall G, Fyrö B, Gullberg B, Nybäck H, Wiesel F-A, Wode-Helgodt B: Relationships in healthy volunteers between concentrations of monoamine metabolites in cerebrospinal fluid and family history of psychiatric morbidity. Br J Psychiatry 136:366-374, 1980
43. Wiesel F-A, Fyrö B, Nybäck H, Sedvall G, Wode-Helgodt B: Relationships in healthy volunteers between secretion of monoamine metabolites in urine, and family history of psychiatric morbidity. Biol Psychiatry 17:1403-1413, 1982
44. Oxenstiema G, Edman G, Iselius L, Oreland L, Ross SB, Sedvall G: Concentrations of monoaminc metabolites in the cerebrospinal fluid of twins and unrelated individuals - A genetic study. J Psychiatr Res. 20:19-29, 1986
45. Farde L, Wiesel F-A, Stone-Elander S, Halldin C, Nordström A-L, Hall H, Sedvall G: D2 dopamine receptors in neuroleptic-naive schizophrenic patients. Arch Gen Psychiatry 47:213-219, 1990
46. Nordström A-L: PET evaluation of dopamine hypotheses for antipsychotic drugs and schizophrenia. Thesis, Stockholm, Karolinska Institute, 1993
47. Jönsson E, Brené S, Geijer T, Terenius L, Tylec A, Persson M-L, Sedvall G: A search for association between schizophrenia and dopamine-related alleles. Eur Arch Psychiatry Clin Neurosci 246:297-304, 1996
48. Geijer T, Telkov M, Terenius L: Characterization of human prodynorphin gene transcripts. Biochem Biophys Res Comm 215:881-888, 1995